CBR96-doxorubicin immunoconjugate: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import |
No edit summary |
| (One intermediate revision by the same user not shown) | |
(No difference)
| |
Latest revision as of 16:50, 22 March 2025
is a humanized monoclonal antibody that targets Lewis-Y antigen used in the treatment of cancer.
 | |
|---|---|
 |
 |
| Monoclonal antibodies for infectious disease and toxins |
|---|
|
| Monoclonals for bone, musculoskeletal, circulatory, and neurologic systems | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Monoclonal antibodies for tumors | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Engineered monoclonal antibodies and antibody mimetics | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
